(The Center Square) – Pro-life groups are holding the U.S. Food and Drug Administration and its commissioner, Marty Makary, accountable for leaving its promise to review the “dangerous” abortion drug ...
Presented by the Coalition to Strengthen America’s Healthcare{beacon} Health Care Health Care PRESENTED BY COALITION TO ...
The Ethics & Public Police Center study found that about 11% of women experience sepsis, infection, hemorrhaging, or another ...
The Biden administration withheld data from the public on the risks of myocarditis from the Covid vaccine, FDA Commissioner ...
Just The News on MSN
Pro-life group calls for Trump admin to fire FDA head Marty Makary over delayed abortion drug report
The move comes after the FDA quietly approved a new generic version of the abortion drug mifepristone in October.
It’s getting out of control. It’s distorting the doctor-patient relationship, these endless pharmaceutical ads,” Makary told “Pod Force One” host Miranda Devine.
The U.S. Food and Drug Administration (FDA) has been rocked by recent changes to several leadership roles while it has ...
The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
No new data supports these label changes, which fly in the face of known science. More than 100,000 women in Kansas City and ...
In her nine months as scientific adviser to U.S. Food and Drug Administration Commissioner Marty Makary, Tracy Beth Høeg’s ...
Dec 3 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has appointed Tracy Beth Hoeg as acting director ...
The Exzolt Cattle-CA1 aka Fluralaner topical drug has received conditional approval from federal regulators to prevent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback